The plaque psoriasis market is witnessing robust expansion driven by rapid advancements in biologics, targeted therapies, and rising global disease prevalence. Increasing adoption of personalized medicine, paired with evolving regulatory approvals, is reshaping industry trends and amplifying market growth strategies.

Market Size and Overview

The plaque psoriasis market is estimated to be valued at USD 32.28 Bn in 2025 and is expected to reach USD 52.17 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.

Current Event & Its Impact on Market

I. Advancement in Biologic Therapies and Regulatory Approvals
- A. FDA’s Fast-Track Approvals of Next-Gen Biologics – Accelerates market growth by enabling faster market entry for novel therapies, thereby expanding the market size and share globally.
- B. Expansion of Teledermatology in North America – Broadens market opportunities by facilitating early diagnosis and personalized treatment plans, improving patient adherence.
- C. Rise in Real-World Evidence (RWE) Adoption – Enhances clinical trial designs, improving market insights and refining market growth strategies for plaque psoriasis.

II. Geopolitical and Economic Factors Impacting Supply Chains
- A. China’s Export Restrictions on Biologic Raw Materials – Disrupts supply chains of key market players in Asia-Pacific, influencing market growth and revenue generation.
- B. European Union’s Policy on Biosimilar Integration – Facilitates competitive pricing pressure, altering Plaque Psoriasis Market Dynamics and market challenges in the regional plaque psoriasis market.
- C. US Inflation and Healthcare Budget Adjustments – Restricts reimbursement policies, impacting patient access and market size in North America.

Impact of Geopolitical Situation on Supply Chain

A significant geopolitical occurrence impacting the plaque psoriasis market supply chain is the ongoing regulatory tightening in China over the export of critical raw materials used in biologic drug manufacturing. For instance, Shenzhen Grepow Battery Co., Ltd. faced supply interruptions in late 2024, affecting the production timelines for key biologics used in plaque psoriasis treatments. This disruption led to delays in product rollouts for several market players, constraining market revenue and challenging the market growth rates in the Asia-Pacific region during the initial quarters of 2025. It underscores the need for diversified supply chain strategies and localized manufacturing to mitigate future risks.

‣ Get more insights on: Plaque Psoriasis Market

‣ Get this Report in Japanese Language: 尋常性乾癬市場

‣ Get this Report in Korean Language:  플라크건선시장